BioAge Labs, Inc.

• BioAge Labs, Inc. Estimates – HAN:Y7G
  TradingView · 23 Oct 2026
• DeepOriginBio partnership accelerates BioAge Labs progress on human aging drug discovery
  Traders Union · 15 Oct 2026
• BioAge and Deep Origin report first validated hits from AI drug discovery collaboration
  AllSci · 15 Oct 2026
• BioAge Labs (NasdaqGS:BIOA) Stock Forecast & Analyst Predictions
  Simply Wall Street · 15 Oct 2026
• Deep Origin, BioAge Launch Multi-Target AI-Driven Drug Discovery Collab
  Contract Pharma · 14 Oct 2026
• BioAge Labs, Deep Origin Collaborate on AI-Driven Drug Discovery
  marketscreener.com · 14 Oct 2026
• Deep Origin Announces Multi-Target AI-Driven Drug Discovery Collaboration with BioAge Labs; Validated Hits Confirmed against First Target
  The Manila Times · 14 Oct 2026
• Deep Origin and BioAge Labs confirm AI-discovered drug hits for cardiometabolic disease targets.
  Pluang · 14 Oct 2026
• UBS initiates BioAge Labs stock coverage at neutral on DME focus
  Investing.com Canada · 12 Oct 2026
• BioAge Labs (BIOA) Slips 3.47% to $6.04 as Shares Drift Toward Lower Support - Up Down Ratio
  https://www.dars.gov.et/ · 08 Oct 2026
• BioAge Labs Initiates Dosing in Phase 2 QUELL-DME Trial for Diabetic Macular Edema
  Kalkine Media · 02 Oct 2026
• BioAge Labs to Present at Upcoming Investor Conferences
  GlobeNewswire · 25 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →